Ozempic for Weight Loss in Bangalore | TODS

GLP-1 Receptor Agonist

Ozempic for Weight Loss in Bangalore

Ozempic (Semaglutide) is transforming weight management with clinical results that demonstrate sustained weight loss. Discover how TODS provides safe, medically supervised Ozempic therapy with comprehensive assessment and ongoing support.

📅 Schedule Your Consultation 💬 WhatsApp: +91 9845 374 457

Understanding Ozempic

The Science Behind Weight Loss Success

Ozempic (Semaglutide) was originally developed for type 2 diabetes management, but its weight loss effects have made it one of the most sought-after medications globally. Unlike simple appetite suppressants, Semaglutide works by mimicking a hormone that regulates appetite and blood sugar.

In Bangalore, where metabolic diseases and obesity-related conditions are increasingly common, Ozempic offers a scientifically-proven option for eligible patients seeking non-surgical weight management. However, proper medical oversight is essential to ensure safety and optimize results.

At TODS, we provide Ozempic therapy within a fully supervised medical weight loss program. This ensures every patient benefits from this powerful medication while maintaining the safety standards that evidence-based medicine demands.

💊

Quick Navigation

01 What Is Ozempic & How Does It Differ From Wegovy? 02 How Semaglutide Produces Weight Loss 03 Key Clinical Trial Data 04 Who Can Use Ozempic for Weight Loss? 05 Starting Semaglutide: Pre-Treatment Assessment 06 Dosing and Titration Schedule 07 Side Effects & Management 08 Ozempic Costs in Bangalore (2026) 09 Frequently Asked Questions 10 Medical Review 11 Serving Bangalore & Nearby Areas 12 Book Your Consultation

The Medication Explained

What Is Ozempic & How Does It Differ From Wegovy?

Ozempic and Wegovy both contain Semaglutide, but they are different products with different approved indications. Ozempic (Novo Nordisk) is approved in India for type 2 diabetes management. Wegovy is the formulation specifically approved for chronic weight management — available in India since June 2025.

In practice, both medications share the same active ingredient, but maximum doses used in obesity treatment (Wegovy goes up to 2.4 mg weekly) are higher than those typically used in diabetes management with Ozempic. Your TODS physician will advise on which product and dose is appropriate for your situation.

The Mechanism

How Semaglutide Produces Weight Loss

Semaglutide works by binding to GLP-1 receptors in the brain, gut, and pancreas. In the brain, it activates areas involved in satiety and reward processing — reducing appetite, decreasing the desire to eat, and diminishing the reward response to food.

In the gut, it slows gastric emptying, meaning food stays in the stomach longer and patients feel full for longer after meals. This is a physiological effect, not willpower. Patients don't simply decide to eat less — their brain and gut physiology change in ways that make eating less the natural outcome.

Brain Effects: Activates satiety centers, reduces cravings

Gut Effects: Slows digestion, increases fullness

Metabolic Effects: Improves insulin sensitivity and glucose control

Paradigm Shift: Obesity treated as a physiological condition, not a character flaw

Evidence-Based Results

Key Clinical Trial Data

📊

14.9%

STEP-1 Trial

Mean body weight reduction at 2.4 mg weekly over 68 weeks in non-diabetic patients — compared to 2.4% with placebo plus lifestyle intervention.

💓

9.6%

STEP-2 Results

Meaningful weight loss in patients with type 2 diabetes at maximum dose, with improved cardiometabolic markers including blood pressure, HbA1c, and lipid profiles.

❤️

26%

SELECT Trial

Risk reduction in major cardiovascular events in people with obesity and established cardiovascular disease, demonstrating benefits beyond weight loss.

Medical Assessment

Who Can Use Ozempic for Weight Loss?

✅

Eligibility Criteria

Semaglutide is appropriate for adults with a BMI of 27.5 or above (South Asian threshold) with at least one weight-related comorbidity, or BMI of 32.5 or above without a comorbidity.

✓ Type 2 diabetes or metabolic syndrome

✓ Hypertension requiring treatment

✓ Dyslipidaemia or cardiovascular disease

✓ Sleep apnoea or joint problems

🏥

PCOS & Insulin Resistance

Semaglutide is increasingly discussed for PCOS patients with insulin resistance, where both metabolic and reproductive outcomes may benefit. Current research is active in this area.

⚠️

Contraindications

Ozempic/Semaglutide is not appropriate for:

× Personal/family history of medullary thyroid carcinoma

× MEN2 syndrome (Multiple Endocrine Neoplasia type 2)

× History of pancreatitis or severe GI disease

× Pregnancy or breastfeeding

× Severe renal or hepatic impairment

Medical Supervision

Starting Semaglutide: Pre-Treatment Assessment

Comprehensive Evaluation

Full metabolic blood panel, body composition analysis, blood pressure and cardiovascular risk assessment, thyroid function testing, and detailed medication review.

Personalized Planning

Discussion of weight history, comorbidities, previous weight loss attempts, lifestyle factors, and realistic goals to establish your individualized treatment plan.

Medication Optimization

Review of current medications (especially diabetes drugs that may require adjustment), drug interactions, and preparation for potential side effects.

Treatment Schedule

Dosing and Titration Schedule

Semaglutide is administered as a once-weekly subcutaneous injection (self-administered at home using a KwikPen). The standard titration schedule is designed to minimize gastrointestinal side effects while achieving therapeutic benefit.

Some patients achieve good results at lower doses and don't require progression to maximum dose. Others need longer at each step. This is completely individualized — your physician adjusts the plan based on your response at each review.

Weeks 1–4: 0.25 mg weekly

Weeks 5–8: 0.5 mg weekly

Weeks 9–12: 1.0 mg weekly

Weeks 13+: 1.7 mg, 2.0 mg, or 2.4 mg (maximum)

Safety & Management

Common Side Effects & How We Manage Them

Most Common Side Effects

Nausea (most frequent early in treatment), constipation or diarrhea, reduced appetite, and occasional headache or fatigue. For most patients, these are mild, transient, and resolve within a few weeks — particularly with gradual titration.

🤢 Nausea — Usually resolves by week 2–3

🔄 GI Changes — Manageable with dietary adjustments

Hair Thinning (Telogen Effluvium)

Reported by some patients and likely due to rapid caloric restriction rather than a direct drug effect. Nutritional monitoring at TODS — including protein intake and micronutrient status — helps minimize this risk.

Pricing Information

Ozempic Costs in Bangalore (2026)

As of mid-2026, Ozempic (Novo Nordisk) starts at approximately ₹1,415 per weekly injection in India. Wegovy (the weight-management-approved formulation) starts at approximately ₹5,660 per month at the 0.25 mg starter dose following Novo Nordisk's April 2026 price reduction of up to 48%.

Generic Semaglutide options (from Natco, Glenmark, and other manufacturers) are now available in India from approximately ₹325 per weekly injection — bringing Semaglutide-based therapy within reach of a much broader patient population.

Medical supervision is equally important regardless of which formulation is prescribed. TODS programme costs — including consultations, investigations, and follow-up — are discussed transparently during your initial assessment.

Ozempic (Original) ~₹1,415/injection

Wegovy (Weight Loss Approved) ~₹5,660/month

Generic Semaglutide ~₹325/injection

TODS Medical Supervision Discussed at consultation

Common Questions

Frequently Asked Questions

Q: Can I use Ozempic for weight loss if I don't have diabetes?

In India, Ozempic is approved for diabetes. For weight loss in non-diabetic patients, Wegovy is now available as the indication-specific formulation. Your TODS physician will advise on the most appropriate option.

Q: How long does it take to see results?

Most patients notice appetite changes within 1–2 weeks. Visible weight loss typically becomes apparent within 4–8 weeks, with significant results accumulating over 12–24 months of treatment.

Q: Is Ozempic safe for long-term use?

Current clinical trial data supports safety over 2+ years. Long-term use is an area of ongoing research. Your TODS physician will review duration and safety as part of your personalized treatment plan.

Q: What happens if I stop Ozempic?

Weight regain is common after stopping Semaglutide. This is why lifestyle anchoring during treatment is critical, and why we include an exit planning phase in our programme.

Q: Is there a generic version available in Bangalore?

Yes. Generic Semaglutide is now available from several Indian manufacturers. Availability in Bangalore and appropriate prescribing can be discussed during your TODS consultation.

Q: Does TODS serve patients from Electronic City?

Yes. Our clinic is accessible from Electronic City, Bannerghatta Road, JP Nagar, and surrounding areas. We offer flexible scheduling for shift workers and IT professionals.

⚕️

Medical Review Notice

Clinical Accuracy Verified

This article has been reviewed for clinical accuracy by the TODS medical team. Information about Ozempic and Wegovy reflects current evidence and regulatory status in India as of mid-2026. This content does not constitute personalized medical advice. Please consult a qualified physician before beginning any weight loss medication.

Reviewed by: Dr. Tulip, MS, FMAS, FIAGES

Senior Bariatric & Metabolic Surgeon | Specialist in Obesity Medicine, Bariatric Surgery, Metabolic Health | TODS India, Bangalore

Serving Bangalore

TODS Clinic: Locally Accessible, Medically Rigorous

💉

Ready to Explore Ozempic for Weight Loss?

Start with a comprehensive medical assessment at TODS. Our physicians will evaluate your health, discuss your weight loss goals, and determine if Ozempic or Wegovy is the right choice for you.

📅 Book Your Consultation 💬 WhatsApp: +91 9845 374 457